CALCULATE YOUR SIP RETURNS

Cohance Lifesciences Shareholding Pattern

COHANCE

Small Cap | Pharmaceuticals

898.30

+19.90 (2.27%)

Suven Pharmaceuticals Ltd - Shareholding FAQs

The promoter shareholding of Suven Pharmaceuticals Ltd is 57.49%.
The FII and DII shareholding of Suven Pharmaceuticals Ltd is 6.51% and 20.82%, respectively.
The retail shareholding of Suven Pharmaceuticals Ltd is 15.18%.

Open Free Demat Account!

Join our 3 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3 Cr+ happy customers